As 2012 comes to a close, NutraIngredients-USA looks back on an action packed year. In the first of our series of galleries capturing the year’s main events, we take a look at the science that made the headlines.
Multivitamins finish 2012 on a high
Described as “the cheapest health insurance a person will ever buy” by Prof Balz Frei from the Linus Pauling Institute at Oregon State University, two high profile studies were published in the Journal of the American Medical Association helped boost the profile of multivitamins.
The first paper reported that a daily multivitamin may reduce the risk of cancer by a modest 8% .
Commenting independently on the study, Prof Frei said: “Given that more than 1.6 million new cancer cases are diagnosed in the U.S. each year, this translates into about 130,000 cancers prevented every year, and with it all the health care costs and human suffering.
“Of course it’s just a supplement, and it’s not a substitute for a good diet and healthy lifestyle. But this study should finally answer all the doubters out there who still think multivitamin supplements have no value. And it further confirms they are completely safe to take.”
Next up was a paper that reported no apparent reduction in the risk of developing heart disease.
The researchers concluded: “These data do not support multivitamin use to prevent CVD, demonstrating the importance of long-term clinical trials of commonly used nutritional supplements.
“Whether to take a daily multivitamin requires consideration of an individual’s nutritional status, because the aim of supplementation is to prevent vitamin and mineral deficiency, plus consideration of other potential effects, including a modest reduction in cancer and other important outcomes in PHS II that will be reported separately.”
Please click here to read our article, Multivitamins may not benefit heart disease risk, but 'don't forget the aim and other potential benefits of supplements
Copyright - Unless otherwise stated all contents of this web site are © 2016 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
The winter months saw a few new hires and promotions, with notable appointments at Sabinsa, CRN, NAXA, Standard...
From breakthrough studies to controversial hypotheses, it has been a fascinating year for science for dietary supplements....
If you didn't make it to Chicago last week for the inaugural Food Vision USA event, you...
The tortoise - rather than the hare – is often the winner in the retail food and...
Ganeden BC30 probiotic is a hot ingredient right now, as demonstrated by a slew of diverse products...